Lineage Cell Therapeutics Statistics
Total Valuation
LCTX has a market cap or net worth of $293.37 million. The enterprise value is $244.84 million.
| Market Cap | 293.37M |
| Enterprise Value | 244.84M |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LCTX has 252.91 million shares outstanding. The number of shares has increased by 8.73% in one year.
| Current Share Class | 252.91M |
| Shares Outstanding | 252.91M |
| Shares Change (YoY) | +8.73% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 4.93% |
| Owned by Institutions (%) | 28.44% |
| Float | 190.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.42 |
| Forward PS | 19.65 |
| PB Ratio | 4.82 |
| P/TBV Ratio | 15.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.61, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.61 |
| Quick Ratio | 6.46 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -60.06% and return on invested capital (ROIC) is -413.84%.
| Return on Equity (ROE) | -60.06% |
| Return on Assets (ROA) | -17.04% |
| Return on Invested Capital (ROIC) | -413.84% |
| Return on Capital Employed (ROCE) | -27.34% |
| Weighted Average Cost of Capital (WACC) | 12.66% |
| Revenue Per Employee | $169,909 |
| Profits Per Employee | -$418,961 |
| Employee Count | 77 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.20% in the last 52 weeks. The beta is 1.55, so LCTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.55 |
| 52-Week Price Change | -7.20% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 1.49 |
| Relative Strength Index (RSI) | 56.85 |
| Average Volume (20 Days) | 847,452 |
Short Selling Information
The latest short interest is 29.56 million, so 11.69% of the outstanding shares have been sold short.
| Short Interest | 29.56M |
| Short Previous Month | 28.19M |
| Short % of Shares Out | 11.69% |
| Short % of Float | 15.49% |
| Short Ratio (days to cover) | 29.53 |
Income Statement
In the last 12 months, LCTX had revenue of $13.08 million and -$32.26 million in losses. Loss per share was -$0.19.
| Revenue | 13.08M |
| Gross Profit | -7.51M |
| Operating Income | -26.85M |
| Pretax Income | -37.39M |
| Net Income | -32.26M |
| EBITDA | -26.11M |
| EBIT | -26.85M |
| Loss Per Share | -$0.19 |
Balance Sheet
The company has $50.83 million in cash and $2.30 million in debt, with a net cash position of $48.53 million or $0.19 per share.
| Cash & Cash Equivalents | 50.83M |
| Total Debt | 2.30M |
| Net Cash | 48.53M |
| Net Cash Per Share | $0.19 |
| Equity (Book Value) | 59.80M |
| Book Value Per Share | 0.24 |
| Working Capital | 44.95M |
Cash Flow
In the last 12 months, operating cash flow was -$23.82 million and capital expenditures -$574,000, giving a free cash flow of -$24.39 million.
| Operating Cash Flow | -23.82M |
| Capital Expenditures | -574,000 |
| Depreciation & Amortization | 739,000 |
| Net Borrowing | -54,000 |
| Free Cash Flow | -24.39M |
| FCF Per Share | -$0.10 |
Margins
Gross margin is -57.36%, with operating and profit margins of -205.23% and -246.58%.
| Gross Margin | -57.36% |
| Operating Margin | -205.23% |
| Pretax Margin | -285.75% |
| Profit Margin | -246.58% |
| EBITDA Margin | -199.58% |
| EBIT Margin | -205.23% |
| FCF Margin | n/a |
Dividends & Yields
LCTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.73% |
| Shareholder Yield | -8.73% |
| Earnings Yield | -11.00% |
| FCF Yield | -8.31% |
Analyst Forecast
The average price target for LCTX is $5.50, which is 374.14% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.50 |
| Price Target Difference | 374.14% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 33.91% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 31, 1997. It was a forward split with a ratio of 3:1.
| Last Split Date | Oct 31, 1997 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
LCTX has an Altman Z-Score of -1.77 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.77 |
| Piotroski F-Score | 3 |